$FREY
FREYR Battery, Inc. /DE/ Stock $frey

$frey Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000199224324000066 Filed on February 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$21.33M	$104.9M
YoY Change		-27.63%	-1.9%
% of Gross Profit
Research & Development	$11.75M	$10.16M	$28.46M
YoY Change	142.46%	132.01%	109.64%
% of Gross Profit
Depreciation & Amortization	$2.211M	$1.422M	$3.344M
YoY Change	962.98%	690.0%	599.58%
% of Gross Profit
Operating Expenses	$34.80M	$32.89M	$143.0M
YoY Change	-0.2%	-2.84%	16.73%
Operating Profit	-$34.80M		-$143.0M
YoY Change	-0.2%		16.73%
Interest Expense	$1.405M	$4.045M	$9.949M
YoY Change	-53.21%	-346.65%	458.93%
% of Operating Profit
Other Income/Expense, Net	$6.112M	$10.40M	$70.56M
YoY Change	-72.43%	-82.79%	201.93%
Pretax Income	-$28.69M	-$24.46M	-$72.43M
YoY Change	125.91%	-197.95%	-26.93%
Income Tax	$0.00	$329.0K	$670.0K
% Of Pretax Income
Net Earnings	-$28.54M	-$24.15M	-$71.95M
YoY Change	124.29%	-195.46%	-27.17%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.20		-$0.51
Diluted Earnings Per Share	-$0.20	-$0.17	-$0.51
COMMON SHARES
Basic Shares Outstanding	139.7M shares		139.7M shares
Diluted Shares Outstanding	139.7M shares		139.7M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$253.3M	$253.3M
YoY Change		-42.83%	-42.83%
Cash & Equivalents	$249.9M	$253.3M	$253.3M
Short-Term Investments
Other Short-Term Assets	$13.64M	$34.04M	$58.62M
YoY Change	-86.31%	319.42%	-57.03%
Inventory
Prepaid Expenses	$1.770M	$2.168M
Receivables
Other Receivables
Total Short-Term Assets	$268.2M	$312.0M	$312.0M
YoY Change	-45.5%	-46.16%	-46.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$354.5M	$366.4M	$390.8M
YoY Change	22.7%	73.81%	73.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.119M	$1.275M	$22.30M
YoY Change	-95.07%
Other Assets	$9.000K	$4.282M	$4.282M
YoY Change		38827.27%
Total Long-Term Assets	$402.1M	$420.2M	$420.2M
YoY Change	27.85%	69.28%	69.31%
TOTAL ASSETS
Total Short-Term Assets	$268.2M	$312.0M	$312.0M
Total Long-Term Assets	$402.1M	$420.2M	$420.2M
Total Assets	$670.3M	$732.2M	$732.2M
YoY Change	-16.9%	-11.54%	-11.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.460M	$18.11M	$18.11M
YoY Change	-28.91%	167.75%	166.37%
Accrued Expenses	$31.42M	$30.79M	$30.79M
YoY Change	-28.59%	-40.15%	-40.1%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$40.04M	$49.18M	$49.18M
YoY Change	-33.6%	-21.4%	-21.43%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$27.44M	$27.44M	$48.29M
YoY Change	-61.51%		7.3%
Total Long-Term Liabilities	$27.44M	$27.44M	$48.29M
YoY Change	-61.51%		7.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$40.04M	$49.18M	$49.18M
Total Long-Term Liabilities	$27.44M	$27.44M	$48.29M
Total Liabilities	$86.60M	$97.47M	$98.99M
YoY Change	-35.42%	-9.39%	-10.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$303.5M	-$275.0M
YoY Change		35.43%
Common Stock	$1.397M	$1.397M
YoY Change		-99.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$582.3M	$633.2M	$633.2M
YoY Change
Total Liabilities & Shareholders Equity	$670.3M	$732.2M	$732.2M
YoY Change	-16.9%	-11.54%	-11.54%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$28.54M	-$24.15M	-$71.95M
YoY Change	124.29%	-195.46%	-27.17%
Depreciation, Depletion And Amortization	$2.211M	$1.422M	$3.344M
YoY Change	962.98%	690.0%	599.58%
Cash From Operating Activities	-$16.22M	-$33.95M	-$87.93M
YoY Change	29.24%	99.48%	-2.31%
INVESTING ACTIVITIES
Capital Expenditures	$21.46M	$19.01M	$187.8M
YoY Change	-66.51%	-81.56%	3.89%
Acquisitions
YoY Change
Other Investing Activities			$845.0K
YoY Change			-85.33%
Cash From Investing Activities	-$2.434M	-$19.01M	-$187.0M
YoY Change	-96.35%	-81.86%	6.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00		$0.00
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-$16.22M	-33.95M	-$87.93M
Cash From Investing Activities	-$2.434M	-19.01M	-$187.0M
Cash From Financing Activities	$0.00		$0.00
Net Change In Cash	-$22.98M	-52.96M	-$287.3M
YoY Change	-73.97%	-140.96%	11027.15%
FREE CASH FLOW
Cash From Operating Activities	-$16.22M	-$33.95M	-$87.93M
Capital Expenditures	$21.46M	$19.01M	$187.8M
Free Cash Flow	-$37.67M	-$52.96M	-$275.8M
YoY Change	-50.83%	-55.91%	1.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001992243
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	333-274434
CY2023	dei	Entity Registrant Name EntityRegistrantName	FREYR Battery, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	93-3205861
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	6&8 East Court Square, Suite 300
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Newnan
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30263
CY2023	dei	City Area Code CityAreaCode	678
CY2023	dei	Local Phone Number LocalPhoneNumber	632-3112
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1200000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	139705234	shares
CY2023	dei	Auditor Firm AuditorFirmId	1318
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers AS
CY2023	dei	Auditor Location AuditorLocation	Oslo, Norway
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	253339000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	443063000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	22403000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	119982000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2168000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	8293000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	34044000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8117000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	311954000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	579455000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	366357000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	210777000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2813000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2963000	usd
CY2023Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	22303000	usd
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	0	usd
CY2023Q4	us-gaap	Debt Securities Noncurrent DebtSecuritiesNoncurrent	0	usd
CY2022Q4	us-gaap	Debt Securities Noncurrent DebtSecuritiesNoncurrent	19954000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	24476000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14538000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4282000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11000	usd
CY2023Q4	us-gaap	Assets Assets	732185000	usd
CY2022Q4	us-gaap	Assets Assets	827698000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	18113000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6765000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30790000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	51446000	usd
CY2023Q4	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	281000	usd
CY2022Q4	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	4367000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	49184000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	62578000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2025000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	33849000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18816000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11144000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	27444000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q4	us-gaap	Liabilities Liabilities	97469000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	107571000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	355000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	245000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139854000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139705000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	139854000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	925623000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	772602000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1041000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18826000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	9094000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274999000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203054000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	633195000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	717455000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	1521000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2672000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	634716000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	720127000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	732185000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	827698000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	108133000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	107357000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	61755000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28457000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13574000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13816000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-62000	usd
CY2023	frey	Convertible Notes Fair Value Adjustment Gain Loss ConvertibleNotesFairValueAdjustmentGainLoss	1074000	usd
CY2022	frey	Convertible Notes Fair Value Adjustment Gain Loss ConvertibleNotesFairValueAdjustmentGainLoss	-277000	usd
CY2021	frey	Convertible Notes Fair Value Adjustment Gain Loss ConvertibleNotesFairValueAdjustmentGainLoss	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-73096000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1151000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-328000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-71945000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-98791000	usd
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75363000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75363000	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-93378000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139705000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139705000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118474000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	118474000	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-73096000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-99119000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-93378000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-27920000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9618000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1182000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-101016000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-89501000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-94560000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1151000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-328000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-99865000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-89173000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-94560000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4956000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	14055000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-93378000	usd
CY2021	frey	Apic Share Based Payment Arrangement Decrease Through Reclassification From Equity To Liability APICShareBasedPaymentArrangementDecreaseThroughReclassificationFromEquityToLiability	8984000	usd
CY2021	frey	Norway Demerger Increase Decrease In Equity NorwayDemergerIncreaseDecreaseInEquity	-2897000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14895000	usd
CY2021	frey	Stock Issued During Period Value New Issues Private Placement StockIssuedDuringPeriodValueNewIssuesPrivatePlacement	579000000	usd
CY2021	frey	Business Combination Net Of Redemptions And Transaction Costs BusinessCombinationNetOfRedemptionsAndTransactionCosts	39020000	usd
CY2021	frey	Luxembourg Reorganization Increase Decrease In Equity LuxembourgReorganizationIncreaseDecreaseInEquity	0	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1052000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022	frey	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	251126000	usd
CY2022	frey	Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability Classified To Equity Classified AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityClassifiedToEquityClassified	1092000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	3000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9618000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	720127000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	15544000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-73096000	usd
CY2023	frey	Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability Classified To Equity Classified AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityClassifiedToEquityClassified	61000	usd
CY2023	frey	Change To Par Value Common Stock Increase Decrease In Equity ChangeToParValueCommonStockIncreaseDecreaseInEquity	0	usd
CY2023	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-27920000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	634716000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-73096000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-99119000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	11595000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	120000	usd
CY2023	frey	Loss On Us Joint Venture Consolidation LossOnUSJointVentureConsolidation	0	usd
CY2022	frey	Loss On Us Joint Venture Consolidation LossOnUSJointVentureConsolidation	1619000	usd
CY2021	frey	Loss On Us Joint Venture Consolidation LossOnUSJointVentureConsolidation	0	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1351000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1458000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-31763000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14183000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	21859000	usd
CY2023	frey	Fair Value Adjustment Of Convertible Notes Increase Decrease FairValueAdjustmentOfConvertibleNotesIncreaseDecrease	-1074000	usd
CY2022	frey	Fair Value Adjustment Of Convertible Notes Increase Decrease FairValueAdjustmentOfConvertibleNotesIncreaseDecrease	277000	usd
CY2021	frey	Fair Value Adjustment Of Convertible Notes Increase Decrease FairValueAdjustmentOfConvertibleNotesIncreaseDecrease	0	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-379000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1557000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-62000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	19648000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	2868000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-469000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	131000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4487000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3664000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	16419000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	230000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20039000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	17385000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10163000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4012000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1594000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-87929000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-90009000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-63136000	usd
CY2023	frey	Proceeds From Property Related Grants Received ProceedsFromPropertyRelatedGrantsReceived	3500000	usd
CY2022	frey	Proceeds From Property Related Grants Received ProceedsFromPropertyRelatedGrantsReceived	10461000	usd
CY2021	frey	Proceeds From Property Related Grants Received ProceedsFromPropertyRelatedGrantsReceived	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	187823000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	180787000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13775000	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1655000	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3000000	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	300000	usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	20000000	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	1000000	usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	2000000	usd
CY2021	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	12000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-186978000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-175026000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33787000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	251124000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1052000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023	frey	Proceeds From Business Combination ProceedsFromBusinessCombination	0	usd
CY2022	frey	Proceeds From Business Combination ProceedsFromBusinessCombination	0	usd
CY2021	frey	Proceeds From Business Combination ProceedsFromBusinessCombination	70836000	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	573666000	usd
CY2023	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	7500000	usd
CY2023	frey	Payments For The Norway Demerger PaymentsForTheNorwayDemerger	0	usd
CY2022	frey	Payments For The Norway Demerger PaymentsForTheNorwayDemerger	0	usd
CY2021	frey	Payments For The Norway Demerger PaymentsForTheNorwayDemerger	3002000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	250072000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	649000000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-12396000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12381000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1395000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-287303000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2582000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	550682000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	563045000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	275742000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	563045000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	565627000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	3000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	269000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	frey	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Conversion To Preferred Stock Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetConversionToPreferredStockIncreaseDecrease	-21028000	usd
CY2022	frey	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Conversion To Preferred Stock Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetConversionToPreferredStockIncreaseDecrease	0	usd
CY2021	frey	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Conversion To Preferred Stock Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetConversionToPreferredStockIncreaseDecrease	0	usd
CY2023	frey	Warrant Liability Assumed From Business Combination WarrantLiabilityAssumedFromBusinessCombination	0	usd
CY2022	frey	Warrant Liability Assumed From Business Combination WarrantLiabilityAssumedFromBusinessCombination	0	usd
CY2021	frey	Warrant Liability Assumed From Business Combination WarrantLiabilityAssumedFromBusinessCombination	27265000	usd
CY2023	frey	Settlement Of Redeemable Preferred Shares Through Issuance Of Ordinary Shares SettlementOfRedeemablePreferredSharesThroughIssuanceOfOrdinaryShares	0	usd
CY2022	frey	Settlement Of Redeemable Preferred Shares Through Issuance Of Ordinary Shares SettlementOfRedeemablePreferredSharesThroughIssuanceOfOrdinaryShares	0	usd
CY2021	frey	Settlement Of Redeemable Preferred Shares Through Issuance Of Ordinary Shares SettlementOfRedeemablePreferredSharesThroughIssuanceOfOrdinaryShares	14895000	usd
CY2023	frey	Reclassification Of Share Based Compensation Expense From Equity To Liability ReclassificationOfShareBasedCompensationExpenseFromEquityToLiability	0	usd
CY2022	frey	Reclassification Of Share Based Compensation Expense From Equity To Liability ReclassificationOfShareBasedCompensationExpenseFromEquityToLiability	0	usd
CY2021	frey	Reclassification Of Share Based Compensation Expense From Equity To Liability ReclassificationOfShareBasedCompensationExpenseFromEquityToLiability	8984000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	22312000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	25360000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	7559000	usd
CY2023	frey	Investment In Equity Method Investment Through Assumption Of Liability InvestmentInEquityMethodInvestmentThroughAssumptionOfLiability	0	usd
CY2022	frey	Investment In Equity Method Investment Through Assumption Of Liability InvestmentInEquityMethodInvestmentThroughAssumptionOfLiability	0	usd
CY2021	frey	Investment In Equity Method Investment Through Assumption Of Liability InvestmentInEquityMethodInvestmentThroughAssumptionOfLiability	3000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	253339000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	443063000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	563956000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	22403000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	119982000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1671000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	275742000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	563045000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	565627000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Use of Estimates</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. </span>Estimates and assumptions include, but are not limited to, estimates related to impairment of long-lived assets, the valuation of warrant liability, share-based compensation, and the convertible note. We base these estimates on historical experiences and on various other assumptions that we believe are reasonable under the circumstances, however, actual results may differ materially from these estimates.
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2900000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2500000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Concentrations of Credit Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial instruments that are potentially subjected to credit risk consist of cash and cash equivalents and restricted cash. Our cash and cash equivalents and restricted cash are placed with major financial institutions. We have not experienced any credit loss related to our cash and cash equivalents and restricted cash.</span></div>
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	116400000	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	116400000	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	116400000	usd
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	116400000	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	116400000	usd
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	245000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	116440191	shares
CY2023	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	58	position
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	6000000	usd
CY2023Q4	frey	Deposits Receivable DepositsReceivable	23893000	usd
CY2022Q4	frey	Deposits Receivable DepositsReceivable	39000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	10151000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	8078000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	34044000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8117000	usd
CY2023Q4	us-gaap	Land Land	44326000	usd
CY2022Q4	us-gaap	Land Land	44326000	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	39723000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	21000	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	14058000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	61000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2926000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2532000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	269197000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	164387000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	370230000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	211327000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3873000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	550000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	366357000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	210777000	usd
CY2023Q4	us-gaap	Area Of Land AreaOfLand	368	acre
CY2023	us-gaap	Depreciation Depreciation	3200000	usd
CY2022	us-gaap	Depreciation Depreciation	400000	usd
CY2021	us-gaap	Depreciation Depreciation	100000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	390833000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	225315000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	150000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	38000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	150000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	150000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	150000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	150000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	150000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1275000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	21028000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	0	usd
CY2023Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	22303000	usd
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	0	usd
CY2023Q4	frey	Accrued Purchases Current AccruedPurchasesCurrent	13145000	usd
CY2022Q4	frey	Accrued Purchases Current AccruedPurchasesCurrent	34932000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13120000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12936000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3382000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3257000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1143000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	321000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30790000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	51446000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P49Y
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3382000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3257000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18816000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11144000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	22198000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	14401000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	3039000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2232000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	621000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	170000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	299000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	157000	usd
CY2023	us-gaap	Lease Cost LeaseCost	3959000	usd
CY2022	us-gaap	Lease Cost LeaseCost	2559000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3503000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3486000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3254000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2191000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2047000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	30444000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	44925000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	22727000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	22198000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P32Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P22Y9M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0712
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0688
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	5088000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2528000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	12240000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	15878000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	24600000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	24600000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q4	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	20000000	usd
CY2021Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.05
CY2022Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	23000000	shares
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	11.50
CY2022Q4	frey	Sale Of Stock Gross Consideration Received On Transaction SaleOfStockGrossConsiderationReceivedOnTransaction	264500000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	245000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139700000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139700000	shares
CY2023Q4	frey	Designated Share Capital Per Share DesignatedShareCapitalPerShare	1.00
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	frey	Ordinary Shares Conversion Ratio OrdinarySharesConversionRatio	1
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	355000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139700000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139700000	shares
CY2023Q4	frey	Common Stock Number Of Vote Units CommonStockNumberOfVoteUnits	1	vote
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	0	shares
CY2022Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	150000	shares
CY2022	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	150000	shares
CY2022	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	6.97
CY2022Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	0	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	148000	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	17100000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	200000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4000000	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2300000	usd
CY2023	frey	Construction In Progress Costs Capitalized ConstructionInProgressCostsCapitalized	0	usd
CY2022	frey	Construction In Progress Costs Capitalized ConstructionInProgressCostsCapitalized	10500000	usd
CY2021	frey	Construction In Progress Costs Capitalized ConstructionInProgressCostsCapitalized	0	usd
CY2022Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	200000	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	176000	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2023	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	267000	usd
CY2022	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2021	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2023	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	227000	usd
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	670000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	225000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	445000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	670000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-72426000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-99119000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-93378000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-15209000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-24720000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23288000	usd
CY2023	frey	Effective Income Tax Rate Reconciliation Loss Gain On Warrant Liability Amount EffectiveIncomeTaxRateReconciliationLossGainOnWarrantLiabilityAmount	6524000	usd
CY2022	frey	Effective Income Tax Rate Reconciliation Loss Gain On Warrant Liability Amount EffectiveIncomeTaxRateReconciliationLossGainOnWarrantLiabilityAmount	-26691000	usd
CY2021	frey	Effective Income Tax Rate Reconciliation Loss Gain On Warrant Liability Amount EffectiveIncomeTaxRateReconciliationLossGainOnWarrantLiabilityAmount	5452000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-1260000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	2197000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1513000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	9345000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	45572000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	16605000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1270000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	3642000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-282000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	670000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	34170000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	61205000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6117000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4080000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	150000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	147000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	40437000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	65432000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	38821000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	64693000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1616000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	739000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	903000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	50000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1158000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	689000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2061000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	739000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	445000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023	frey	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Including Foreign Exchange Amount EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceIncludingForeignExchangeAmount	-25900000	usd
CY2022	frey	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Including Foreign Exchange Amount EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceIncludingForeignExchangeAmount	45600000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	156300000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-71945000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-71945000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-98791000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-98791000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-93378000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-93378000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139705000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139705000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118474000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	118474000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75363000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75363000	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	37965000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33325000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29911000	shares
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001992243-24-000066-index-headers.html	Edgar Link	pending
0001992243-24-000066-index.html	Edgar Link	pending
0001992243-24-000066.txt	Edgar Link	pending
0001992243-24-000066-xbrl.zip	Edgar Link	pending
ex1017-employmentagreement.htm	Edgar Link	pending
ex211-q42023.htm	Edgar Link	pending
ex231-q42023.htm	Edgar Link	pending
ex311-q42023.htm	Edgar Link	pending
ex312-q42023.htm	Edgar Link	pending
ex321-q42023.htm	Edgar Link	pending
ex322-q42023.htm	Edgar Link	pending
ex45-q42023xdescriptionofs.htm	Edgar Link	pending
ex97-q42023xclawbackpolicy.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
frey-20231231.htm	Edgar Link	pending
frey-20231231.xsd	Edgar Link	pending
frey-20231231_g1.jpg	Edgar Link	pending
frey-20231231_g2.jpg	Edgar Link	pending
image_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
frey-20231231_def.xml	Edgar Link	unprocessable
frey-20231231_lab.xml	Edgar Link	unprocessable
frey-20231231_pre.xml	Edgar Link	unprocessable
frey-20231231_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
frey-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FREY
FREYR Battery, Inc. /DE/ Stock $frey

2024 Q1 Form 10-K Financial Statement

#000199224324000066 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FREY FREYR Battery, Inc. /DE/ Stock $frey

2024 Q1 Form 10-K Financial Statement

#000199224324000066 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FREY
FREYR Battery, Inc. /DE/ Stock $frey